Pfizer’s Paxlovid Ineffective Against Long COVID Using 15-Day Regimen: Study
BioSpace
JUNE 10, 2024
While a prolonged, 15-day regimen of Paxlovid is safe, it appears to be ineffective at lowering the symptoms of long COVID, according to results of a Phase II trial funded by Pfizer and conducted by Stanford Medicine.
Let's personalize your content